SynVivo is a leader in human-relevant organ-on-a-chip technology, providing advanced 3D in vitro models that replicate the native tissue microenvironment for drug discovery, toxicology, and translational research. Our cell-based microfluidic platforms integrate the precision of bioengineering and microvascular flow to deliver predictive, real-time data on cellular behavior, drug delivery, and therapeutic response.
SynVivo’s proprietary organ-on-a-chip platforms—including SynBBB™ (blood-brain barrier chip), SynTumor™ (cancer-on-a-chip), SynALI™ (lung-on-a-chip), SynRAM™ (inflammation-on-a-chip), and SynTox™ (toxicology-on-a-chip)—bridge the gap between traditional preclinical models and human biology. Each platform enables dynamic flow and shear stress, supporting a microvascular network that mimics natural circulation for more accurate modeling of BBB transcytosis, tumor microenvironments, respiratory infection, immunotoxicology, and systemic toxicology.
